Switching Foldamer Helices

Reflecting work in the Legrand Lab

Published here August 25, 2026

Azole γ-Peptides Helix Switching via Heterocycle Substitutions

Samantha Chaise, Claude Didierjean, Audrey Gacogne, Maxime Fillaudeau, Young Kee Kang, Aurélien Lebrun, Jean-Louis Bantignies, Dominique Housset, Muriel Amblard, Ludovic T. Maillard, Baptiste Legrand

Angew. Chem. Int. Ed. 2026, e9299244. https://doi.org/10.1002/anie.9299244

View Original Publication


Controlling which helix a foldamer adopts has proven difficult. Most strategies rely on chiral centers, bulky side chains, or metal coordination to bias backbone conformation, and these approaches offer limited flexibility once the monomer is committed to a fold. The thiazole-based γ-amino acid ATC folds reliably into a right-handed 9-Helix stabilized by nine-membered intramolecular hydrogen bonds and an attractive 1,4-S⋅⋅⋅O stereoelectronic interaction between the heterocycle and the carboxamide. Theory predicted that Z-vinylogous γ-peptides could also access a 7-Helix, but no synthetic route to that alternative state had been demonstrated. The challenge was not only to reach the 7-Helix but to understand, at the electronic level, why one heteroatom arrangement favors one fold over another.

Researchers in the Legrand Group at the University of Montpellier, published in Angewandte Chemie International Edition, reasoned that the intraresidue stereoelectronic balance within the heterocycle is the primary conformational determinant, and that rebalancing it through heteroatom permutation or substitution should redirect folding without redesigning the entire scaffold. Permuting the sulfur and nitrogen within the parent ATC thiazole ring yields the isomeric residue ATC*, in which sulfur now engages in attractive S⋅⋅⋅N chalcogen interactions with the adjacent amide, competing directly with the seven-membered hydrogen bond that would otherwise close a C7-turn. DFT and natural bond orbital analyses quantify this competition and reveal an unusual left-handed stretched helix with alternating hydrogen-bonded and non-hydrogen-bonded residues, confirmed by microcrystal electron diffraction of an ATC* octamer. Replacing sulfur with oxygen in the oxazole analogue AOC* removes the competing chalcogen interaction, strengthens the C7 hydrogen bond, and drives AOC* oligomers into a regular, continuous left-handed 7-Helix fully characterized by NMR, FT-IR, and circular dichroism.

The work establishes heteroatom identity within the heterocyclic ring as a legible conformational code for azole γ-peptides, enabling deliberate navigation among distinct helical topologies from a shared synthetic platform. The 7-Helix geometry differs from any canonical protein secondary structure, and the authors point toward future comparisons of its biological properties with those of the 9-Helix scaffold, including antimicrobial activity, amyloid inhibition, and organocatalysis.


Author

Prof. Ludovic Maillard is Pharmacyst, Paris XI, 2002, and Chemical Engineer, ENSCP, Paris VI, 2002. After a Master Degree in organic chemistry, Paris VI, 2002, he did a Ph.D. in bioorganic chemistry at the ICSN, in the group of Dr. B. Badet. Thereafter he joined the group of Prof. J. Robinson at OCI, Zurich, Switzerland, for a one-year postdoctoral training before becoming Associate Professor of medicinal chemistry at the Faculty of Pharmacy of Montpellier. One of his major research interests is to develop and characterized conformationaly predictable molecular architectures named foldamers, which are constructed from heterocyclic γ-amino acids. In such a context, he has reported a short chemical route to access orthogonally protected thiazole-based γ-amino acids, which were used as building blocks for designing helical γ-peptide foldamers and antimicrobial peptides. These platforms are highly versatile, and efforts are made to expand their applications toward cellular targeting and organo-catalysis.

Author

Dr. Baptiste Legrand earned his Ph.D. in Life Sciences and Health, structural biology, from the University of Rennes 1 in 2009, and then spent two years as a postdoctoral fellow at the Laboratory of Macromolecular Chemistry and Physics, LCPM, Nancy, where he characterized foldamer structures by combining NMR, CD and FTIR spectroscopies with molecular dynamics simulations. He joined the IBMM in 2012. His research is devoted to rationally designed architectures for applications in health with a focus on three-dimensional structure determination, on the mechanisms governing the folding and stability of complex edifices at the atomic scale, and on peptide self-assemblies. Current applications include the development of antimicrobials and of protein–protein interaction inhibitors. Since September 2023, Baptiste has been an elected member of the board of the Groupe Français des Peptides et Protéines, GFPP, French Peptide Society.

Switching Foldamer Helices

Author

Dr. Samantha Chaise holds a master's degree in Biomolecular Chemistry, Synthesis, Separation and Applied Analysis, from the University of Montpellier. From 2021 to 2024, she carried out her doctoral research at the Institut des Biomolécules Max Mousseron, IBMM, in the "Amino Acids, Heterocycles, Peptides and Proteins" group, under the supervision of Dr. Ludovic Maillard and Dr. Baptiste Legrand. Her thesis, entitled "Modulating stereoelectronic effects as a strategy for the diversification of heterocyclic γ-peptides", explored the synthesis of novel heterocyclic γ-amino acids to finely control γ-peptide structures. Since 2025, she has been a postdoctoral researcher in the group of Dr. Béatrice Gerland at the SPCMIB, Laboratoire de Synthèse et Physico-Chimie de Molécules d'Intérêt Biologique, CNRS – University of Toulouse III Paul Sabatier, where she works on the synthesis and functionalization of oligonucleotides for the development of serine protease mimics.